Roberto Azar
Impact in
- Infectious Diseases top 10%
- Viral gastroenteritis research and epidemiology
- SARS-CoV-2 and COVID-19 Research
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Viral gastroenteritis research and epidemiology 5
- SARS-CoV-2 and COVID-19 Research 4
- SARS-CoV-2 detection and testing 4
- Epidemiology 12
- Respiratory viral infections research 8
- Virology and Viral Diseases 3
- Co-authors
- Ella Mendelson (18 shared papers)Michal Mandelboim (10 shared papers)Musa Y. Hindiyeh (9 shared papers)Noemi Varsano (5 shared papers)Virginia Levy (8 shared papers)Zehava Grossman (4 shared papers)Liora Regev (3 shared papers)S Oren (1 shared paper)
In The Last Decade
Roberto Azar
23 papers receiving 621 citations
Peers
Comparison fields: 5 of 56
- Infectious Diseases 224
- Molecular Medicine 43
- Epidemiology 257
- Rheumatology 96
- Applied Microbiology and Biotechnology 12
Countries citing papers authored by Roberto Azar
This map shows the geographic impact of Roberto Azar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Azar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Azar more than expected).
Fields of papers citing papers by Roberto Azar
This network shows the impact of papers produced by Roberto Azar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Azar. The network helps show where Roberto Azar may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Azar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 202 | |
| 2 | 2005 | 69 | |
| 3 | 1993 | 40 | |
| 4 | 2010 | 39 | |
| 5 | 2006 | 37 | |
| 6 | 2007 | 34 | |
| 7 | 2010 | 33 | |
| 8 | 2013 | 30 | |
| 9 | 2014 | 29 | |
| 10 | 1997 | 29 | |
| 11 | 1998 | 26 | |
| 12 | 2016 | 26 | |
| 13 | 2021 | 17 | |
| 14 | 2022 | 13 | |
| 15 | 2018 | 11 | |
| 16 | 2022 | 9 | |
| 17 | 2018 | 7 | |
| 18 | 2021 | 4 | |
| 19 | 1995 | 4 | |
| 20 | 2023 | 3 |
About Roberto Azar
Roberto Azar is a scholar working on Infectious Diseases, Epidemiology, Cardiology and Cardiovascular Medicine, Molecular Medicine and Pollution, having authored 25 papers that have together received 666 indexed citations. Recurring topics across this work include Respiratory viral infections research (8 papers), Viral gastroenteritis research and epidemiology (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), SARS-CoV-2 detection and testing (4 papers), Viral Infections and Immunology Research (4 papers), Virology and Viral Diseases (3 papers), Virus-based gene therapy research (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Infectious Diseases (224 citations), Molecular Medicine (43 citations), Epidemiology (257 citations), Rheumatology (96 citations) and Applied Microbiology and Biotechnology (12 citations). Roberto Azar has collaborated with scholars based in Israel, Italy and Denmark. Frequent co-authors include Ella Mendelson, Michal Mandelboim, Musa Y. Hindiyeh, Noemi Varsano, Virginia Levy, Zehava Grossman, Liora Regev, S Oren, Jacob Nadav Ablin and Dan Caspi. Their work appears in journals such as Journal of Clinical Microbiology, Microbiology Spectrum, Viruses, PLoS ONE and Journal of Clinical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.